BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11320032)

  • 1. Proliferative activity and p53 expression in primary and recurrent pterygia.
    Chowers I; Pe'er J; Zamir E; Livni N; Ilsar M; Frucht-Pery J
    Ophthalmology; 2001 May; 108(5):985-8. PubMed ID: 11320032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p53 tumor suppressor gene in pterygia.
    Weinstein O; Rosenthal G; Zirkin H; Monos T; Lifshitz T; Argov S
    Eye (Lond); 2002 Sep; 16(5):619-21. PubMed ID: 12194078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors.
    Dushku N; Reid TW
    Curr Eye Res; 1997 Dec; 16(12):1179-92. PubMed ID: 9426949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.
    Liang K; Jiang Z; Ding BQ; Cheng P; Huang DK; Tao LM
    Mol Vis; 2011; 17():1687-93. PubMed ID: 21738398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium.
    Assimakopoulou M; Pagoulatos D; Nterma P; Pharmakakis N
    Mol Med Rep; 2017 Oct; 16(4):5285-5293. PubMed ID: 28849159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and significance of p53 protein and Ki-67 protein in pterygium.
    Ljubojević V; Gajanin R; Amidzić L; Vujković Z
    Vojnosanit Pregl; 2016 Jan; 73(1):16-20. PubMed ID: 26964379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
    Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
    Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p63 and p16 in primary and recurrent pterygia.
    Ramalho FS; Maestri C; Ramalho LN; Ribeiro-Silva A; Romão E
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1310-4. PubMed ID: 16523297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival autograft for pterygium.
    Clearfield E; Muthappan V; Wang X; Kuo IC
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011349. PubMed ID: 26867004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity and p53 expression in pterygia.
    Shimmura S; Ishioka M; Hanada K; Shimazaki J; Tsubota K
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1364-9. PubMed ID: 10798651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium.
    Tan DT; Lim AS; Goh HS; Smith DR
    Am J Ophthalmol; 1997 Mar; 123(3):404-5. PubMed ID: 9063255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells.
    Dushku N; Reid TW
    Curr Eye Res; 1994 Jul; 13(7):473-81. PubMed ID: 7924411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of stem cell factor in pterygium.
    Nakagami T; Watanabe I; Murakami A; Okisaka S; Ebihara N
    Jpn J Ophthalmol; 2000; 44(3):193-7. PubMed ID: 10913635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
    Miyagami M; Nakamura S
    No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of p53, p21 and PCNA in pterygium.
    Ueda Y; Kanazawa S; Kitaoka T; Dake Y; Ohira A; Ouertani AM; Amemiya T
    Acta Histochem; 2001 Apr; 103(2):159-65. PubMed ID: 11368097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors.
    Dushku N; Hatcher SL; Albert DM; Reid TW
    Arch Ophthalmol; 1999 Dec; 117(12):1593-9. PubMed ID: 10604662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate.
    Gumus K; Karakucuk S; Mirza GE; Akgun H; Arda H; Oner AO
    Br J Ophthalmol; 2014 Jun; 98(6):796-800. PubMed ID: 23376569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the expression of CD30 in pterygia compared to healthy conjunctivas.
    Garfias Y; Bautista-De Lucio VM; García C; Nava A; Villalvazo L; Jiménez-Martínez MC
    Mol Vis; 2009 Oct; 15():2068-73. PubMed ID: 19862340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
    Costa MJ; Walls J; Ames P; Roth LM
    Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision.
    Prabhasawat P; Barton K; Burkett G; Tseng SC
    Ophthalmology; 1997 Jun; 104(6):974-85. PubMed ID: 9186439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.